Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

7 terminated/withdrawn out of 42 trials

Success Rate

79.4%

-7.1% vs industry average

Late-Stage Pipeline

14%

6 trials in Phase 3/4

Results Transparency

33%

9 of 27 completed trials have results

Key Signals

4 recruiting9 with results

Enrollment Performance

Analytics

Phase 2
9(37.5%)
Phase 4
5(20.8%)
Phase 1
5(20.8%)
N/A
4(16.7%)
Phase 3
1(4.2%)
24Total
Phase 2(9)
Phase 4(5)
Phase 1(5)
N/A(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials
NCT06549218Not ApplicableRecruiting

Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project

Role: collaborator

NCT05279079Completed

Markers in Acute Pancreatitis-1

Role: collaborator

NCT04396366Phase 2Terminated

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis

Role: collaborator

NCT05780151Phase 4Completed

Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

Role: collaborator

NCT06748937Phase 2Recruiting

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Role: collaborator

NCT06042803Recruiting

UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk

Role: collaborator

NCT03349801Active Not Recruiting

Development of Novel Clinical Endpoints in Intermediate AMD

Role: collaborator

NCT03329092Phase 3Completed

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

Role: collaborator

NCT06569888Not ApplicableNot Yet Recruiting

Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of Reflecting the Inflammatory State in the Affected Colonic Tract of Ulcerative Colitis Patients

Role: collaborator

NCT04307953Phase 2Recruiting

Saracatinib Trial TO Prevent FOP

Role: collaborator

NCT02802631Phase 1Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults

Role: collaborator

NCT04711356Phase 2Completed

Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)

Role: collaborator

NCT04304963Completed

Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS

Role: collaborator

NCT03291158Phase 1Withdrawn

Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV

Role: collaborator

NCT04750330Completed

Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection

Role: collaborator

NCT04186000Phase 2Completed

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Role: collaborator

NCT02523287Phase 4Completed

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

Role: collaborator

NCT02555540Phase 4Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Role: collaborator

NCT03756766Active Not Recruiting

Understanding RSV: Severe Disease and the Long Term Consequences

Role: collaborator

NCT04810104Phase 2Withdrawn

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

Role: collaborator